Emma Bolderson Selected Research

Immunoconjugates (Immunoconjugate)

1/2020

The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emma Bolderson Research Topics

Disease

14	Neoplasms (Cancer) 04/2024 - 06/2006
12	Genomic Instability 01/2023 - 05/2008
7	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023 - 12/2004
4	Lung Neoplasms (Lung Cancer) 12/2023 - 01/2020
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 10/2020
3	Breast Neoplasms (Breast Cancer) 01/2024 - 05/2014
3	Progeria (Hutchinson Gilford Syndrome) 01/2021 - 12/2014
2	Triple Negative Breast Neoplasms 01/2024 - 05/2014
2	Adenocarcinoma 09/2021 - 10/2020
2	Chromosomal Instability (Chromosome Stability) 04/2010 - 08/2009
2	Hypersensitivity (Allergy) 04/2010 - 08/2009
1	Colorectal Neoplasms (Colorectal Cancer) 01/2024
1	Cicatrix (Scar) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Xeroderma Pigmentosum (Kaposi's Disease) 10/2021
1	Premature Aging 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 06/2014
1	Familial Breast Cancer 05/2014
1	Genetic Translocation (Chromosomal Translocation) 01/2014

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2009
15	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 12/2004
6	Phosphotransferases (Kinase)IBA 01/2023 - 12/2004
4	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2023 - 04/2010
4	PlatinumIBA 09/2021 - 01/2020
3	Messenger RNA (mRNA)IBA 04/2024 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2014
3	ChromatinIBA 01/2021 - 08/2012
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2020
3	DNA-Binding Proteins (DNA Binding Protein)IBA 04/2013 - 05/2008
2	Small Interfering RNA (siRNA)IBA 01/2024 - 11/2016
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 10/2009
2	chloropyramineIBA 10/2020 - 11/2016
2	Indicators and Reagents (Reagents)IBA 10/2020 - 08/2009
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 10/2009
1	Aurora Kinase BIBA 01/2024
1	Fluorouracil (Carac)FDA LinkGeneric 01/2024
1	Hormones (Hormone)IBA 01/2024
1	3,3,5,5-tetramethyl-1-pyrroline N-oxide (TMPO)IBA 01/2024
1	emerinIBA 01/2024
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	DNA-Activated Protein KinaseIBA 01/2023
1	AndrogensIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 09/2021
1	ErbB Receptors (EGF Receptor)IBA 09/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	NucleophosminIBA 01/2016
1	Alanine (L-Alanine)FDA Link 12/2014
1	Threonine (L-Threonine)FDA Link 12/2014
1	CamptothecinIBA 06/2014
1	HeterochromatinIBA 08/2012
1	Co-Repressor ProteinsIBA 08/2012
1	human EXO1 proteinIBA 04/2010
1	Antineoplastic Agents (Antineoplastics)IBA 10/2009
1	Carrier Proteins (Binding Protein)IBA 10/2009
1	dimemorfan (AT 17)IBA 06/2006
1	Ataxia Telangiectasia Mutated ProteinsIBA 12/2004

Therapy/Procedure

15	Therapeutics 01/2024 - 10/2009
7	Drug Therapy (Chemotherapy) 01/2024 - 10/2009
3	Immunotherapy 01/2021 - 01/2020
1	Radiotherapy 01/2023